StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report issued on Saturday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance NAVB opened at $0.05 on Friday. The stock has a market capitalization of $5.01 million, a price-to-earnings ratio of -0.17 and a beta of […]
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report released on Tuesday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of Navidea Biopharmaceuticals stock opened at $0.09 on Tuesday. The firm has a market capitalization of $9.32 million, a PE ratio […]
StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report published on Sunday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance NAVB opened at $0.11 on Friday. The firm has a market cap of $11.38 million, a PE ratio of -0.39 and a beta of […]
StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report report published on Saturday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Trading Up 23.4 % Shares of NAVB opened at $0.10 on Friday. Navidea Biopharmaceuticals has a 12 month low of $0.06 and a 12 […]
StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report released on Friday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance NYSE NAVB opened at $0.08 on Friday. Navidea Biopharmaceuticals has a 1 year low of $0.06 and a 1 year high of $0.39. The […]